Cargando…
Corrigendum: Entire CD3ε, δ, and γ humanized mouse to evaluate human CD3–mediated therapeutics
Autores principales: | Ueda, Otoya, Wada, Naoko A., Kinoshita, Yasuko, Hino, Hiroshi, Kakefuda, Mami, Ito, Tsuneo, Fujii, Etsuko, Noguchi, Mizuho, Sato, Kiyoharu, Morita, Masahiro, Tateishi, Hiromi, Matsumoto, Kaoru, Goto, Chisato, Kawase, Yosuke, Kato, Atsuhiko, Hattori, Kunihiro, Nezu, Junichi, Ishiguro, Takahiro, Jishage, Kou-ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857968/ https://www.ncbi.nlm.nih.gov/pubmed/29553142 http://dx.doi.org/10.1038/srep46960 |
Ejemplares similares
-
Entire CD3ε, δ, and γ humanized mouse to evaluate human CD3–mediated therapeutics
por: Ueda, Otoya, et al.
Publicado: (2017) -
Novel genetically-humanized mouse model established to evaluate efficacy of therapeutic agents to human interleukin-6 receptor
por: Ueda, Otoya, et al.
Publicado: (2013) -
SGLT5 Reabsorbs Fructose in the Kidney but Its Deficiency Paradoxically Exacerbates Hepatic Steatosis Induced by Fructose
por: Fukuzawa, Taku, et al.
Publicado: (2013) -
A humanized CD3ε-knock-in mouse model for pre-clinical testing of anti-human CD3 therapy
por: Crespo, Joel, et al.
Publicado: (2021) -
Identification of the Transgenic Integration Site in Immunodeficient tgε26 Human CD3ε Transgenic Mice
por: Ohigashi, Izumi, et al.
Publicado: (2010)